• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核心岩藻糖基化缺失通过增强 PD-1 降解增强细胞毒性 T 淋巴细胞的抗癌活性。

Loss of core fucosylation enhances the anticancer activity of cytotoxic T lymphocytes by increasing PD-1 degradation.

机构信息

College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China.

Tianjin Medical University Cancer Institute and Hospital. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin. Tianjin's Clinical Research Center for Cancer, Tianjin, China.

出版信息

Eur J Immunol. 2020 Nov;50(11):1820-1833. doi: 10.1002/eji.202048543. Epub 2020 Sep 3.

DOI:10.1002/eji.202048543
PMID:32460355
Abstract

As an immune checkpoint, programmed cell death 1 (PD-1) and its ligand (PD-L1) pathway plays a crucial role in CD8 cytotoxic T lymphocytes (CTL) activation and provides antitumor responses. The N-glycans of PD-1 and PD-L1 are highly core fucosylated, which are solely catalyzed by the core fucosyltransferase (Fut8). However, the precise biological mechanisms underlying effects of core fucosylation of PD-1 and PD-L1 on CTL activation have not been fully understood. In this study, we found that core fucosylation was significantly upregulated in lung adenocarcinoma. Compared to those of Fut8 OT-I mice, the lung adenocarcinoma formation induced by urethane was markedly reduced in Fut8 OT-I mice. De-core fucosylation of PD-1 compromised its expression on Fut8 CTL, resulted in enhanced Fut8 CTL activation and cytotoxicity, leading to more efficient tumor eradication. Indeed, loss of core fucosylation significantly enhanced the PD-1 ubiquitination and in turn led to the degradation of PD-1 in the proteasome. Our current work indicates that inhibition of core fucosylation is a unique strategy to reduce PD-1 expression for the antilung adenocarcinoma immune therapy in the future.

摘要

作为免疫检查点,程序性细胞死亡蛋白 1(PD-1)及其配体(PD-L1)途径在 CD8 细胞毒性 T 淋巴细胞(CTL)的激活中起着至关重要的作用,并提供抗肿瘤反应。PD-1 和 PD-L1 的 N-糖基高度核心岩藻糖化,这仅由核心岩藻糖基转移酶(Fut8)催化。然而,PD-1 和 PD-L1 的核心岩藻糖化对 CTL 激活的影响的确切生物学机制尚未完全了解。在这项研究中,我们发现核心岩藻糖化在肺腺癌中显著上调。与 Fut8 OT-I 小鼠相比,在 Fut8 OT-I 小鼠中,由尿烷诱导的肺腺癌形成明显减少。PD-1 的去核心岩藻糖化削弱了其在 Fut8 CTL 上的表达,导致 Fut8 CTL 的激活和细胞毒性增强,从而更有效地清除肿瘤。事实上,核心岩藻糖化的缺失显著增强了 PD-1 的泛素化,进而导致 PD-1 在蛋白酶体中的降解。我们目前的工作表明,抑制核心岩藻糖化是未来抗肺腺癌免疫治疗中降低 PD-1 表达的一种独特策略。

相似文献

1
Loss of core fucosylation enhances the anticancer activity of cytotoxic T lymphocytes by increasing PD-1 degradation.核心岩藻糖基化缺失通过增强 PD-1 降解增强细胞毒性 T 淋巴细胞的抗癌活性。
Eur J Immunol. 2020 Nov;50(11):1820-1833. doi: 10.1002/eji.202048543. Epub 2020 Sep 3.
2
Ablation of core fucosylation attenuates the signal transduction via T cell receptor to suppress the T cell development.核心岩藻糖基化的消除通过 T 细胞受体减弱信号转导,从而抑制 T 细胞的发育。
Mol Immunol. 2019 Aug;112:312-321. doi: 10.1016/j.molimm.2019.06.011. Epub 2019 Jun 21.
3
Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells.核心岩藻糖基化的阻断降低PD-1的细胞表面表达并促进T细胞的抗肿瘤免疫反应。
Cell Rep. 2017 Aug 1;20(5):1017-1028. doi: 10.1016/j.celrep.2017.07.027.
4
Core Fucosylation on T Cells, Required for Activation of T-Cell Receptor Signaling and Induction of Colitis in Mice, Is Increased in Patients With Inflammatory Bowel Disease.T 细胞核心岩藻糖化作用对于 T 细胞受体信号的激活以及诱导小鼠结肠炎是必需的,在炎症性肠病患者中增加。
Gastroenterology. 2016 Jun;150(7):1620-1632. doi: 10.1053/j.gastro.2016.03.002. Epub 2016 Mar 8.
5
Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase reveals that it catalyzes core fucosylation of -glycans lacking α1,3-arm GlcNAc.重新审视哺乳动物α1,6-岩藻糖基转移酶的底物特异性发现,它催化缺乏α1,3-臂GlcNAc的聚糖的核心岩藻糖基化。
J Biol Chem. 2017 Sep 8;292(36):14796-14803. doi: 10.1074/jbc.M117.804070. Epub 2017 Jul 20.
6
Loss of core fucosylation suppressed the humoral immune response in Salmonella typhimurium infected mice.核心岩藻糖基化缺失抑制了鼠伤寒沙门氏菌感染小鼠的体液免疫反应。
J Microbiol Immunol Infect. 2021 Aug;54(4):606-615. doi: 10.1016/j.jmii.2020.02.006. Epub 2020 Feb 21.
7
Mammalian α-1,6-Fucosyltransferase (FUT8) Is the Sole Enzyme Responsible for the N-Acetylglucosaminyltransferase I-independent Core Fucosylation of High-mannose N-Glycans.哺乳动物α-1,6-岩藻糖基转移酶(FUT8)是负责高甘露糖型N-聚糖的不依赖于N-乙酰葡糖胺基转移酶I的核心岩藻糖基化的唯一酶。
J Biol Chem. 2016 May 20;291(21):11064-71. doi: 10.1074/jbc.M116.720789. Epub 2016 Mar 23.
8
Core Fucosylation of the T Cell Receptor Is Required for T Cell Activation.T 细胞受体的核心岩藻糖基化对于 T 细胞的激活是必需的。
Front Immunol. 2018 Jan 29;9:78. doi: 10.3389/fimmu.2018.00078. eCollection 2018.
9
Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.肿瘤相关巨噬细胞浸润与早期肺腺癌中肿瘤程序性死亡配体 1 的表达有关。
Cancer Sci. 2020 Feb;111(2):727-738. doi: 10.1111/cas.14272. Epub 2020 Jan 6.
10
Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes.岩藻糖化增强过继转移的抗原特异性细胞毒性 T 淋巴细胞的疗效。
Clin Cancer Res. 2019 Apr 15;25(8):2610-2620. doi: 10.1158/1078-0432.CCR-18-1527. Epub 2019 Jan 15.

引用本文的文献

1
Essential cell-intrinsic requirement for GMDS in T cell development.GMDS在T细胞发育中对细胞内在的基本需求。
Front Immunol. 2025 Jun 26;16:1598923. doi: 10.3389/fimmu.2025.1598923. eCollection 2025.
2
Advances in cancer research on FUT8Molecular mechanisms and clinical applications.FUT8的癌症研究进展:分子机制与临床应用
Int J Surg. 2025 Jun 10;111(9):6290-304. doi: 10.1097/JS9.0000000000002669.
3
FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors.岩藻糖基转移酶8是前列腺肿瘤生长的关键驱动因素,可使用岩藻糖基化抑制剂进行靶向治疗。
Cancer Med. 2025 May;14(10):e70959. doi: 10.1002/cam4.70959.
4
Targeting PD-1 post-translational modifications for improving cancer immunotherapy.靶向程序性死亡受体1(PD-1)的翻译后修饰以改善癌症免疫治疗
Cell Insight. 2025 Apr 10;4(3):100248. doi: 10.1016/j.cellin.2025.100248. eCollection 2025 Jun.
5
Inhibition of PHB1/PHB2 suppresses atherosclerotic plaque formation by interrupting PI3K/AKT/mTOR signaling.抑制PHB1/PHB2可通过中断PI3K/AKT/mTOR信号传导来抑制动脉粥样硬化斑块形成。
PLoS One. 2025 Apr 1;20(4):e0320509. doi: 10.1371/journal.pone.0320509. eCollection 2025.
6
Glycoscience in Advancing PD-1/PD-L1-Axis-Targeted Tumor Immunotherapy.糖科学推动PD-1/PD-L1轴靶向肿瘤免疫治疗
Int J Mol Sci. 2025 Jan 31;26(3):1238. doi: 10.3390/ijms26031238.
7
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers.靶向PD-1/PD-L1信号通路用于癌症治疗:聚焦生物标志物。
Int J Mol Sci. 2025 Jan 31;26(3):1235. doi: 10.3390/ijms26031235.
8
Cytoplasmic FBXO38 mediates PD-1 degradation.细胞质 FBXO38 介导 PD-1 降解。
EMBO Rep. 2024 Oct;25(10):4168-4171. doi: 10.1038/s44319-024-00254-y. Epub 2024 Sep 16.
9
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets.泛素修饰在肿瘤免疫治疗耐药机制调控及潜在治疗靶点中的作用
Exp Hematol Oncol. 2024 Aug 30;13(1):91. doi: 10.1186/s40164-024-00552-0.
10
N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment.PD-L1/PD-1 的 N -linked 糖基化:癌症诊断和治疗的新兴靶点。
J Transl Med. 2024 Jul 30;22(1):705. doi: 10.1186/s12967-024-05502-2.